Whether it’s setting up a Bank of England-type body to run it or fining patients for missing appointments, healthcare leaders, policymakers and practitioners past and present have a wealth of ideas about how they would change the NHS for the better.
How Boehringer Ingelheim and Pfizer battled over the exclusivity of the first Humira interchangeable
Ten companies are now competing for market share with AbbVie’s megablockbuster rheumatoid arthritis drug Humira (adalimumab), but two of those competitors — Pfizer and Boehringer